Oncorus Correlations
| ONCRDelisted Stock | USD 0.04 0.01 14.71% |
The current 90-days correlation between Oncorus and Altamira Therapeutics is -0.03 (i.e., Good diversification). The correlation of Oncorus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Oncorus Correlation With Market
Average diversification
The correlation between Oncorus and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and DJI in the same portfolio, assuming nothing else is changed.
Oncorus |
Moving together with Oncorus Stock
| 0.74 | NVO | Novo Nordisk AS | PairCorr |
| 0.74 | NONOF | Novo Nordisk AS | PairCorr |
| 0.92 | CSLLY | CSL | PairCorr |
| 0.88 | CMXHF | CSL Limited | PairCorr |
| 0.86 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.7 | VLCN | Volcon Inc | PairCorr |
| 0.77 | AULT | Ault Alliance Symbol Change | PairCorr |
| 0.68 | AKO-B | Embotelladora Andina | PairCorr |
| 0.9 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.81 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.63 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
Moving against Oncorus Stock
| 0.92 | PLTR | Palantir Technologies Aggressive Push | PairCorr |
| 0.75 | BMA | Banco Macro SA | PairCorr |
| 0.64 | AMKBY | AP Moeller Maersk | PairCorr |
| 0.48 | KAKZF | Kaspi Bank Joint | PairCorr |
| 0.47 | BRK-A | Berkshire Hathaway | PairCorr |
| 0.38 | KB | KB Financial Group | PairCorr |
| 0.89 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.88 | DIS | Walt Disney Aggressive Push | PairCorr |
| 0.85 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
| 0.83 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.73 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.73 | T | ATT Inc Aggressive Push | PairCorr |
| 0.67 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.64 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.49 | HPQ | HP Inc | PairCorr |
| 0.43 | HD | Home Depot Sell-off Trend | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Oncorus Stock performing well and Oncorus Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oncorus' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EFTR | 7.57 | (4.57) | 0.00 | (470.75) | 0.00 | 8.70 | 88.91 | |||
| APLM | 6.40 | 0.07 | 0.00 | 0.01 | 0.00 | 8.40 | 134.75 | |||
| ANGN | 5.04 | 0.71 | 0.13 | 0.61 | 5.44 | 11.55 | 42.18 | |||
| SGTX | 14.93 | 4.84 | 0.72 | 0.55 | 6.43 | 12.46 | 442.39 | |||
| PYXS | 3.89 | (0.76) | 0.00 | (10.48) | 0.00 | 6.41 | 61.13 | |||
| ZURA | 3.79 | (0.66) | 0.00 | (0.19) | 0.00 | 7.95 | 26.70 | |||
| CYTO | 3.53 | (1.15) | 0.00 | (8.98) | 0.00 | 6.98 | 22.81 | |||
| ELEV | 3.51 | (0.48) | 0.00 | (0.11) | 0.00 | 5.77 | 22.21 | |||
| LABP | 3.55 | 0.43 | 0.09 | 0.58 | 3.81 | 8.58 | 19.47 |
Oncorus Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncorus stock to make a market-neutral strategy. Peer analysis of Oncorus could also be used in its relative valuation, which is a method of valuing Oncorus by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Oncorus Corporate Management
| Richard MBA | Chief CFO | Profile | |
| Brian Shea | Director Sec | Profile | |
| Chris German | Controller | Profile | |
| Stephen Harbin | COO Staff | Profile | |
| Mitchell Finer | NonEx Chairman | Profile | |
| John MD | Chief Officer | Profile |
Still Interested in Oncorus?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.